U.S. federal trademark · Serial No. 90281316
Matriptimab is a novel antibody-drug conjugate that targets activated matriptase, a tumor antigen expressed almost exclusively on cancer cells
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.